SEER
Seer, Inc. NASDAQ Listed Dec 4, 2020$1.74
+1.16%
vs $1.72
Mkt Cap $100.0M
52w Low $1.66
11.3% of range
52w High $2.37
50d MA $1.84
200d MA $1.93
P/E (TTM)
-1.4x
EV/EBITDA
—
P/B
0.4x
Debt/Equity
0.1x
ROE
-28.4%
P/FCF
-2.2x
RSI (14)
25.90
ATR (14)
$0.05
Beta
1.60
50d MA
$1.84
200d MA
$1.93
Avg Volume
206.7K
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
3800 Bridge Parkway · Redwood City, CA 94065 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -0.32 | -0.29 | +9.4% | 2.08 | -15.4% | -17.3% | +0.6% | +4.0% | +2.8% | -0.5% | — |
| Nov 6, 2025 | AMC | -0.32 | -0.32 | +0.0% | 2.16 | -0.9% | -3.2% | +0.0% | -1.0% | +0.5% | -1.9% | — |
| Aug 6, 2025 | AMC | -0.39 | -0.33 | +15.4% | 2.06 | +0.5% | -2.4% | +14.4% | -3.9% | -0.5% | -1.4% | — |
| May 13, 2025 | AMC | -0.37 | -0.34 | +8.1% | 1.92 | +9.9% | +9.9% | -1.4% | -0.5% | +0.0% | +1.0% | — |
| Feb 27, 2025 | AMC | -0.31 | -0.34 | -9.7% | 2.20 | +0.0% | -4.5% | -1.9% | -1.0% | +0.0% | -2.0% | — |
| Nov 6, 2024 | AMC | -0.29 | -0.34 | -17.2% | 2.07 | -2.4% | +7.2% | +7.2% | -5.9% | +0.9% | +2.2% | — |
| Aug 8, 2024 | AMC | -0.36 | -0.35 | +2.8% | 1.73 | -0.6% | -0.6% | -1.2% | +0.0% | -2.4% | +1.8% | — |
| May 8, 2024 | AMC | -0.31 | -0.32 | -3.2% | 2.23 | -6.7% | -7.6% | -2.9% | -0.5% | +8.5% | -0.9% | — |
| Feb 29, 2024 | AMC | -0.35 | -0.28 | +20.0% | 1.82 | -1.1% | +0.0% | +5.5% | -0.5% | +5.2% | +3.5% | — |
| Nov 7, 2023 | AMC | -0.38 | -0.33 | +13.2% | 1.72 | -4.1% | -5.2% | -0.9% | -3.4% | +1.9% | +4.4% | — |
| Aug 8, 2023 | AMC | -0.38 | -0.37 | +2.6% | 4.66 | -4.5% | -33.7% | -9.7% | -1.4% | +2.2% | -4.3% | — |
| May 9, 2023 | AMC | -0.37 | -0.38 | -2.7% | 3.64 | -0.8% | -4.4% | -5.2% | -4.2% | +4.4% | -1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4 | Canaccord Genuity | Initiates | Buy | $4 | $2.03 | $2.05 | +1.0% | -3.9% | -4.6% | +1.6% | -0.5% | -0.5% |
| Aug 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $1.70 | $1.70 | +0.0% | +0.0% | -2.4% | +1.8% | +0.0% | -1.8% |
| Feb 21 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $4.44 | $4.14 | -6.8% | -11.3% | +0.8% | -1.0% | -5.3% | +5.1% |
| Jan 4 | BofA Securities | Downgrade | Neutral → Underperform | — | $5.85 | $5.52 | -5.6% | -22.1% | -7.0% | +8.5% | +9.6% | +12.5% |
| Nov 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.79 | $7.16 | +5.4% | +20.3% | +5.0% | -8.9% | +5.0% | -9.1% |
| Aug 11 | JP Morgan | Downgrade | Overweight → Neutral | — | $13.31 | $12.28 | -7.7% | -19.7% | +11.4% | -0.9% | -7.5% | +0.0% |
| Aug 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $13.31 | $12.28 | -7.7% | -19.7% | +11.4% | -0.9% | -7.5% | +0.0% |
| May 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $9.04 | $8.91 | -1.4% | -0.4% | +3.2% | -13.5% | -4.1% | -8.9% |
| Mar 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.32 | $14.85 | -3.1% | -10.0% | +0.4% | -4.8% | -5.2% | -4.1% |
| Feb 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.41 | $15.89 | +3.1% | +3.9% | -2.2% | -9.6% | -9.5% | +0.2% |
| Aug 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $29.85 | $29.32 | -1.8% | +8.8% | -6.3% | -2.2% | -0.9% | +1.7% |
| May 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $31.96 | $31.13 | -2.6% | -10.0% | +0.1% | +2.8% | +4.1% | +3.7% |
| Mar 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $41.05 | $40.65 | -1.0% | +5.3% | +15.7% | +4.3% | +8.9% | -3.3% |
| Dec 29 | JP Morgan | Maintains | Overweight → Overweight | — | $64.40 | $63.99 | -0.6% | -14.2% | +2.3% | -0.7% | -3.8% | +7.6% |
| Dec 29 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $64.40 | $63.99 | -0.6% | -14.2% | +2.3% | -0.7% | -3.8% | +7.6% |
| Dec 29 | TD Cowen | Maintains | Outperform → Outperform | — | $64.40 | $63.99 | -0.6% | -14.2% | +2.3% | -0.7% | -3.8% | +7.6% |
No insider trades available.
8-K · 8.01
!! High
Seer, Inc. -- 8-K 8.01: Material Event / Announcement
May 22
8-K · 8.01
!! High
Seer, Inc. -- 8-K 8.01: Material Event / Announcement
Seer received a revised unsolicited acquisition proposal from Bradley Radoff and Michael Torok on April 24, 2026, though the offer remains non-binding and highly contingent, leaving the company's strategic options open.
Apr 27
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
SEER received an unsolicited acquisition proposal from Bradley L., requiring board review but carrying no certainty of deal completion, creating uncertainty that could drive near-term stock volatility.
Apr 13
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Seer successfully defended its core protein enrichment patent against Bruker's challenge, protecting key intellectual property and competitive moat that validates its proprietary technology differentiation.
Mar 30
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Seer's appointment of Computershare as transfer agent signals institutional infrastructure maturity and may facilitate future equity issuances or public company operational scaling.
Mar 16
8-K
Seer, Inc. -- 8-K Filing
Seer reports full year 2025 financial results and provides 2026 guidance, indicating the proteomics company's operational performance and management's outlook for continued business development.
Feb 26
8-K · 1.01
!! High
Seer, Inc. -- 8-K 1.01: Material Agreement
Seer, Inc. entered into a material agreement with Computershare Trust Co., likely involving transfer agent services or equity plan administration, which supports operational infrastructure for shareholder management.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Softbank Group Corp. | 5,135,383 | $9M | — | Mar 2026 |
| 2 | Acadian Asset Management Llc | 2,074,709 | $3M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,958,996 | $3M | New | Mar 2026 |
| 4 | Renaissance Technologies Llc | 976,688 | $2M | Reduced | Mar 2026 |
| 5 | Aju Ib Investment Co., Ltd. | 816,375 | $2M | — | Mar 2026 |
| 6 | Nano Cap New Millennium Growth Fund L P | 825,000 | $2M | New | Dec 2025 |
| 7 | Two Sigma Investments, Lp | 511,598 | $859K | Added | Mar 2026 |
| 8 | Peapod Lane Capital Llc | 438,581 | $736K | — | Mar 2026 |
| 9 | Morgan Stanley | 342,736 | $627K | Reduced | Dec 2025 |
| 10 | Rangeley Capital, Llc | 184,302 | $310K | Added | Mar 2026 |
| 11 | Northern Trust Corp | 134,560 | $226K | Added | Mar 2026 |
| 12 | D.e. Shaw & Co | 125,154 | $210K | Reduced | Mar 2026 |
| 13 | Edgewood Management Llc | 100,000 | $168K | — | Mar 2026 |
| 14 | Royal Bank Of Canada | 71,617 | $120K | — | Mar 2026 |
| 15 | Palumbo Wealth Management Llc | 67,187 | $113K | Reduced | Mar 2026 |
| 16 | Bank Of America Corp /de/ | 57,072 | $96K | Reduced | Mar 2026 |
| 17 | Ubs Group Ag | 48,396 | $81K | Added | Mar 2026 |
| 18 | Barclays Plc | 48,211 | $81K | Reduced | Mar 2026 |
| 19 | Jane Street Group, Llc | 43,222 | $79K | Reduced | Dec 2025 |
| 20 | Marshall Wace, Llp | 45,790 | $77K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$100.0M
Enterprise Value
-$64.9M
P/E (TTM)
-1.36x
Forward P/E
—
PEG Ratio
0.18x
P/B
0.39x
P/S
6.03x
P/FCF
-2.16x
EV/EBITDA
—
Shares Out
57.4M
Financials (TTM)
Revenue
$16.6M
Net Income
-$73.6M
EBITDA
-$66.2M
Free Cash Flow
-$46.2M
Op Cash Flow
-$44.4M
EPS Basic
$-1.28
EPS Diluted
$-1.28
EPS Forward
$-1.08
Gross Margin
51.1%
Op Margin
-470.5%
Net Margin
-444.0%
Balance Sheet
Total Assets
$296.1M
Total Liab.
$36.8M
Total Equity
$259.3M
Cash
$185.9M
LT Debt
$21.1M
Book Value/Sh
$4.51
Debt/Equity
0.09x
Current Ratio
12.84
Quick Ratio
12.35
Returns & Growth
ROE
-28.4%
ROA
-24.9%
ROIC
-27.6%
Rev Growth YoY
+18.9%
EPS Growth YoY
+7.9%
Price Returns
2W
+6.9%
1M
-4.1%
3M
+8.7%
6M
-2.6%
12M
-2.6%
Technicals
52W High
$2.37
52W Low
$1.66
50d MA
$1.84
200d MA
$1.93
RSI (14)
25.90
ATR (14)
$0.05
Beta
1.60
Avg Volume
207K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 27, 2026 12:39am
· Source: financialmodelingprep.com